As of 2025-07-09, the Intrinsic Value of Antibe Therapeutics Inc (ATE.TO) is -1.77 CAD. This ATE.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.30 CAD, the upside of Antibe Therapeutics Inc is -701.01%.
Based on its market price of 0.30 CAD and our intrinsic valuation, Antibe Therapeutics Inc (ATE.TO) is overvalued by 701.01%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.77 - -1.77 | -1.77 | -701.01% |
| P/E | (6.31) - (9.47) | (7.89) | -2774.5% |
| DDM - Stable | (3.47) - (32.89) | (18.18) | -6263.0% |
| DDM - Multi | (0.11) - (0.84) | (0.20) | -167.7% |
| Market Cap (mil) | 15.53 |
| Beta | -0.16 |
| Outstanding shares (mil) | 52.65 |
| Enterprise Value (mil) | 11.43 |
| Market risk premium | 5.10% |
| Cost of Equity | 8.06% |
| Cost of Debt | 5.00% |
| WACC | 5.88% |